Showing results (951-960 of 6,955) with videos related to
Sort By:
Pageof 696
Journal of Clinical Pharmacology|April 28, 2006
Ritonavir has minimal impact on the pharmacokinetic disposition of a single dose of bupropion administered to human volunteersLeah M Hesse, David J Greenblatt, Lisa L von Moltke, et al.Journal of Clinical Pharmacology|August 1, 1991
Prophylactic antiparkinson drug use: II. Withdrawal after long-term maintenance therapyM R Lavin, A RifkinJournal of Clinical Pharmacology|March 24, 2006
The comparability of etanercept pharmacokinetics in healthy Japanese and American subjectsShinichi Kawai, Hisayuki Sekino, Noriaki Yamashita, et al.Journal of Clinical Pharmacology|March 24, 2006
Determination of the bioavailability of [14C]-hexaminolevulinate using accelerator mass spectrometry after intravesical administration to human volunteersB Klem, G Lappin, S Nicholson, et al.Journal of Clinical Pharmacology|March 24, 2006
Antiplatelet activity during coadministration of the selective serotonin reuptake inhibitor paroxetine and aspirin in male smokers: a randomized, placebo-controlled, double-blind trialNicole Kotzailias, Toni Andonovski, Alexander Dukic, et al.Journal of Clinical Pharmacology|September 22, 2006
Pharmacokinetic evaluation and safety profile of a 15-minute versus 30-second infusion of palonosetron in healthy subjectsAjit Shah, Timothy DeGroot, Glen ApseloffJournal of Clinical Pharmacology|September 22, 2006
Population pharmacokinetic analysis and dosing regimen optimization of meropenem in adult patientsChonghua Li, Joseph L Kuti, Charles H Nightingale, et al.Journal of Clinical Pharmacology|July 21, 2006
Drug utilization pattern in the intensive care unit of a tertiary care hospitalS Biswal, P Mishra, S Malhotra, et al.Journal of Clinical Pharmacology|February 27, 2007
Absolute and relative bioavailability of fentanyl buccal tablet and oral transmucosal fentanyl citrateMona Darwish, Mary Kirby, Philmore Robertson, et al.Journal of Clinical Pharmacology|February 27, 2007
Predictive population pharmacokinetic/pharmacodynamic model for a novel COX-2 inhibitorS Rohatagi, H Kastrissios, Y Gao, et al.Pageof 696